Hepatic Pathophysiology Flashcards

1
Q

Acute Hepatitis

A

Liver inflammation d/t viral infection, drug reaction, exposure to hepatotoxin (i.e. alcohol or carbon tetrachloride)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Fulminant Hepatic Failure

A

Presents as rapid, massive necrosis of liver parenchyma & ↓liver size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute Viral Hepatitis

A

A oral-fecal route
B & C transmitted primarily percutaneously & via bodily fluid contact
Other viruses D, E, Epstein-Barr, Herpes Simplex, Cytomegalovirus, & Coxsackievirsus

Prodromal illness 1-2wks w/ fatigue, malaise, low-grade fever, N/V
Period may or may not be follow by jaundice - typically lasts 2-12wks
Complete recovery aeb normal serum transaminases usually takes 4mos
Clinical courses complicated & prolonged w/ Hepatitis B/C viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hepatitis A

A

Least severe
Most patients recover in week to months
Transmission via fecal contamination
Common in 3rd world countries d/t improper sanitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hepatitis B

A

HBsAg (surface antigen)
Often anicteric - does not present w/ jaundice
→ fulminant hepatic necrosis or chronic hepatitis
HBsAg disappears w/ recovery but disease able to be diagnosed through Hepatitis B antibody presence
Transmission via sexual contact or blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hepatitis C

A

Antibodies not present for long period
Difficult to diagnosis - exclusion primarily
Subclinical non-icteric infection common
Rarely produces fulminant hepatic failure
Significant number those who are chronically infected will develop cirrhosis or liver cancer
20% percent develop cirrhosis (major cause hepatocellular carcinoma)
Produces asymptomatic carriers
No effective vaccine currently available
Transmission via blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hepatitis E

A

Similar to Hepatitis A
3rd world countries
Transmission via fecal contamination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chronic Viral Hepatitis

A

Chronic active viral hepatitis = acute hepatitis byproduct
3-10% after B virus infection
At least 50% after C virus infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chronic Viral Hepatitis

A

Chronic active viral hepatitis = acute hepatitis byproduct
3-10% after B virus infection
At least 50% after C virus infection

Asymptomatic infectious carriers

  1. 3-30% patients w/ Hepatitis B (persistent HBsAg present in blood)
  2. 5-1% patient w/ Hepatitis C remain infectious (correlates w/ amount Hepatitis C viral RNA in blood)

Avoid contact w/ blood & secretions
Immunization highly effective against Hepatitis B infection
No Hepatitis C vaccine available & prior infection does not = immunity upon re-exposure
Post-exposure prophylaxis w/ hyperimmune globulin effect for Hepatitis B not C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drug-Induced Acute Hepatitis

A

Clinical course resembles viral hepatitis
Difficult diagnosis
Most common cause = alcohol-induced
Other causes: Tylenol, salicylates, carbon tetrachloride, volatile anesthetics, Phenytoin, sulfonamides, Rifampin, Indomethacin, Isoniazid, Amiodarone, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute Hepatitis

Preop Considerations

A

Postpone elective surgery
↑periop morbidity & mortality
Further hepatic dysfunction & failure risk
- Encephalopathy
- Coagulopathy
- Hepatorenal syndrome
Labs: BUN, creatinine, bilirubin, electrolytes, glucose, transaminase, alk phos, albumin, PT/INR, plt count
- Hep B HBsAg
- ETOH blood alcohol level
Hypokalemia & metabolic acidosis d/t vomiting
Hypomagnesemia in chronic alcoholics → predisposes to dysrhythmias
Correct dehydration & electrolyte abnormalities
Hypoalbuminemia usually not present except in protracted cases w/ severe malnutrition or chronic hepatitis
N/V → RSI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ALT > AST

A

ACUTE hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AST > ALT

A

Alcoholic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Synthetic Liver Function

A

PT = best indicator
Prolongation >3-4sec (INR <1.5) following vitamin K (correct coagulopathy onset 24hr) admin indicates severe liver dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute Hepatitis

Intraop Considerations

A

GOAL = preserve existing hepatic function
Individualized drug selection & dosages
Acute viral hepatitis → CNS sensitivity to aesthetics
Alcoholic patients (unless acute intoxication) display cross-tolerance to IV & volatile anesthetic agents, require CV monitoring d/t additive depressant effects & possible alcoholic cardiomyopathy
↓anesthetic agents
Inhalational agents are generally preferable to IV agents d/t dependence on liver metabolism & elimination
Standard induction doses IV agents generally used d/t action terminated by redistribution vs. metabolism or excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Volatile Agent

A

Isoflurane - least effect on hepatic blood flow
Avoid ↓hepatic blood flow
- Hypotension, excessive SNS stimulation, ↑mean airway pressure during controlled ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chronic Hepatitis

A

Persistent hepatic inflammation >6mos aeb ↑serum aminotransferases
Classification based on 3 distinct syndromes (determined by liver biopsy)
- Chronic persistent hepatitis
- Chronic lobular hepatitis
- Chronic active hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chronic Persistent Hepatitis

A

Present w/ acute Hepatitis (B or C) that has protracted course but eventually resolves
Characterized by chronic portal tract inflammation w/ normal cellular architecture preservation (minimal cell death)
Usually does not progress to cirrhosis (typically resolves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chronic Lobular Hepatitis

A

Present w/ acute hepatitis that resolves but followed by recurrent exacerbations
Characterized by inflammation foci & cellular necrosis in the lobules
Usually does not progress to cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Chronic Active Hepatitis

A

Occurs most commonly after acute Hepatitis B or C episode
Characterized by chronic hepatic inflammation w/ cellular architecture destruction → global
Evidence of cirrhosis present initially or eventually develops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic Hepatitis

Lab Values

A

Mild elevation serum aminotransferases & generally correlate poorly w/ disease severity

22
Q

Chronic Hepatitis Treatment

A

Antiviral medications
Hep B - antiviral + immune modulator drugs (interferon)
Hep C - antiviral cure >95% patients

23
Q

Chronic Hepatitis

Anesthetic Management

A

Chronic persistent or chronic lobular hepatitis treat similar to acute hepatitis patients
Assume all chronic active hepatitis have cirrhosis & treat accordingly

24
Q

Cirrhosis General Considerations

A

Progressive disease that eventually results in hepatic failure
Result = hepatocyte necrosis followed by fibrosis & nodular regeneration
Destruction
→ portal vein obstruction → portal HTN
→ normal synthetic & metabolic function impairment → multisystem disease
Jaundice & ascites
Spider angiomas, palmar erythema, gynecomastia, & splenomegaly

25
Cirrhosis CAUSES
Alcohol abuse Non-alcoholic fatty liver disease Chronic active hepatitis (B & C) Chronic biliary inflammation or obstruction
26
Cirrhosis Complications
Variceal hemorrhage d/t portal HTN Intractable fluid retention → ascites Hepatic encephalopathy or coma
27
Childs-Turcotte-Pugh Score
Surgical risk r/t hepatic impairment degree ``` Total bilirubin Serum albumin INR Ascites Hepatic encephalopathy ``` Points 5-6 = Class A 100% 1 year → 85% 2 year survival 7-9 = Class B 80% → 60% 10-15 = Class C 45% → 35%
28
Cirrhosis Hematological
Portal hypertension S/S → gastroesophageal, hemorrhoidal, periumbilical, retroperitoneal varices, & dilated abdominal wall veins Variceal bleeding treatment - IVF, blood products, vasopressin, propranolol, balloon tamponade, endoscopic sclerosis or varices ligation Anemia, thrombocytopenia, coagulopathy, leukopenia Excessive blood transfusions → encephalopathy Correct coagulopathy before surgery Replace clotting factors w/ blood products (i.e. FFP & cryoprecipitate) Platelet count <100,000 → transfusion
29
Cirrhosis Cardiovascular
Hyperdynamic circulatory state ↑CO & generalized peripheral vasodilation AV shunts R → L develop in systemic & pulmonary circulation Cirrhotic cardiomyopathy d/t AV shunts & ↓blood viscosity → ↑CO Alcoholic cardiomyopathy → CHF
30
Cirrhosis Respiratory
Hyperventilation common & results in 1° respiratory alkalosis Hypoxemia frequent d/t R → L shunt - ↑anomalous AV communication - V/Q mismatch - 40% CO involved ↓lung volumes (particularly FRC) d/t ascites fluid elevates the diaphragm → atelectasis CXR & ABG Paracentesis to treat massive ascites w/ pulmonary compromise
31
Cirrhosis Renal & Fluid Balance
Ascites, edema, electrolyte abnormalities, hepatorenal syndrome Portal HTN ↑hydrostatic pressure fluid transudation across the intestine into the peritoneum Hypoalbuminemia ↓plasma oncotic pressure → fluid transudation Protein-rich lymph fluid 2° distortion & obstruction lymphatic channels Renal Na+ & H2O retention d/t hepatorenal syndrome ↓renal perfusion, altered intrarenal hemodynamics, enhanced proximal & distal tubule Na+ reabsorption, impairment free water clearance Dilutional hyponatremia Hypokalemia - excessive K+ loss 2° hyperaldosteronism or diuretics Judicious preop fluid management - Ascites & edema diuresis over several days - Loop diuretics only after bed rest, Na+ restriction, & Spironolactone therapy failed Preserve renal function Correct intravascular fluid deficits w/ colloid infusion
32
Hepatorenal Syndrome
Functional deficit in patients w/ cirrhosis Causes: GI bleeding, aggressive diuresis, sepsis, major surgery S/S: Na+ retention, progressive oliguria, azotemia, intractable ascites High mortality rate Treatment = supportive & often unsuccessful unless liver transplant performed
33
Cirrhosis CNS
Hepatic encephalopathy - mental status alterations, asterixis, hyperreflexia, EEG changes, ↑ICP Treat encephalopathy preop *Avoid sedatives Metabolic encephalopathy r/t hepatocellular damage & degree portal blood shunting directly into systemic circulation → accumulation toxins originating from GI tract (ammonia, methionine metabolites, short chain fatty acids, phenols)
34
Hepatic Encephalopathy | Precipitating Factors
``` 1° GI bleeding ↑dietary protein intake ↑ammonia Hypokalemic alkalosis d/t vomiting or diuresis Infections Worsening liver function ```
35
Drug Response
``` CNS sensitivity Vd Protein binding Metabolism Elimination ``` Titrate, titrate, titrate
36
NMBs
↑Vd highly ionized NMBs ↑loading dose ↓hepatic elimination ↓maintenance dose
37
Cirrhosis | Intraop Anesthetic Considerations
Cirrhotic liver dependent on hepatic arterial blood flow d/t reduced portal blood flow Avoid anesthetic agents that potentially ↓hepatic arterial blood flow Regional anesthesia w/o thrombocytopenia or coagulopathy avoid hypotension Propofol or Thiopental induction w/ Isoflurane Choice NMB = Cisatracurium Opioid supplementation ↓volatile agent requirement but prolonged elimination 1/2 time → prolonged respiratory depression RSI induction w/ cricoid pressure CV unstable patient or w/ active bleeding → awake intubation
38
Cirrhosis Monitoring
``` 5-lead EKG ABGs to evaluate acid-base status R → L shunts A-line to monitor rapid BP changes (excessive bleeding, fluid shifts, surgical manipulations) CVP or PAP UOP Large bore IVs ```
39
Cirrhosis Fluid Replacement
Na+ restriction preop Intraabdominal procedures associated w/ excessive bleeding (venous engorgement d/t portal HTN, adhesions from previous surgery, coagulopathy) & fluid shifts (ascites evacuation & prolonged surgical procedures) Anemia + coagulopathy → blood transfusion preop Significant transfusions → citrate toxicity
40
Citrate
Hepatic metabolism Cirrhosis impairs citrate metabolism Citrate bind to serum Ca2+ & leads to hypocalcemia IV Ca2+ often necessary to reverse the negative inotropic effects r/t ↓iCal
41
Hepatobiliary Disease
Cholestasis - impaired bile outflow Most common cause = biliary tract extrahepatic obstruction Also caused by intrahepatic obstruction ↑conjugated bilirubin >50% ↑alkaline phosphatase OR cholecystectomy d/t cholecystitis Treatment - NG suction, IVF, antibiotics, opioid analgesics High bilirubin levels associated w/ renal failure Long-term extrahepatic biliary obstruction associated w/ 2° biliary cirrhosis & portal HTN
42
Extrahepatic Obstruction
Obstruction d/t gallstones, stricture, or tumor w/in common bile duct Treatment - surgical (remove blockage)
43
Intrahepatic Obstruction
Bile flow suppression or stoppage at hepatocyte or bile canaliculus level Most commonly results from viral hepatitis or idiosyncratic drug reaction Treatment - medical (inflammation)
44
Gallstone Disease
Cholelithiasis Present w/ biliary colic 2° to cystic duct obstruction Gallstones obstruct pancreatic duct → acute pancreatitis
45
Cholangtitis
Concomitant chills or high fever suggest an ascending bacterial infection of the biliary system
46
Vitamin K
Vitamin K deficiency d/t extrahepatic biliary obstruction Full response requires 24 hours PT unable to correct prior to surgery after vitamin K admin FFP
47
Hepatobiliary Disease | Intraop Considerations
Opioids → problematic w/ intraop cholangiogram d/t induce Sphincter of Oddi spasm → false + Treatment = Naloxone or Glucagon Biliary tract obstruction expect prolong DOA in drugs dependent on biliary excretion (i.e. Propofol or Ketamine) Agents dependent on renal excretion are preferable Monitor UOP Maintain periop diuresis
48
Hepatic Surgery
Common surgeries - laceration repairs, abscess drainage, tumor resection 80-85% liver able to be resected Complications - blood loss Cirrhosis complicates anesthetic management & ↑periop mortality Multiple large bore IVs, fluid/blood warmers, rapid infusion devices, A-line, CVP, avoid hypotension Admin antifibrinolytics ↓blood loss (i.e. Aprotinin, Aminocaproic acid, Tranexamic acid) Hypoglycemia following liver resections Abscess drainage complicated by peritoneal contamination
49
Postop Complications
Bleeding Sepsis Hepatic dysfunction Mechanical ventilation postop after extensive resection
50
HEPATITIS
Hepatitis (liver inflammation) d/t virus/toxin/fatty liver disease → Acute (fulminant liver failure) d/t Hep B/D or Acetaminophen → 80-90% hepatocyte function loss → encephalopathy/coagulopathy → 1° cause death cerebral edema d/t ↑NH3 in brain & accumulation glutamate & neuronal swelling Chronic liver disease d/t alcohol/Hep C/non-alcoholic fatty liver disease → hepatocellular death or cirrhosis Hepatocellular death ↓synthesis/clearance/metabolic derangement → encephalopathy/coagulopathy Cirrhosis → risk hepatocellular cancer or portal HTN Portal HTN → ascites/varices/death d/t varices bleeding
51
Preop Clinical Assessment
``` Cirrhosis 6-80% mortality - Lap chole 1-6% - TURP 7% - Umbilical herniorrhaphy 13% - Non-lap biliary 20% - Abdominal trauma 47% - Peptic ulcer 54% - Emergency abdominal 57% - Emergency cardiac 80% Chronic hepatitis 0% Hep C lap chole 0% Acute hepatitis ex lap 100% Obstructive jaundice abdominal surgery 5-60% ```